Soligenix expands European medical board for lymphoma drug approval push

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/3/2026

1. PANW
2. SPY
3. ULTA
4. GTLB
5. USO
6. CRWD
7. GOOGL
8. MDT
9. VRTS
10. AVGO

Go back to Soligenix expands European medical board for lymphoma drug approval push
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.48 -0.27 (36%)
Previous Close $0.75    52 Week High $4.35 
Open $0.60    52 Week Low $0.44 
Day High $0.62    P/E N/A 
Day Low $0.46    EPS $-0.81 
Volume 6,756,876